Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China

Abstract

To evaluate the pharmacoeconomics of three therapeutic schemes in treating anti-tuberluosis therapy -induced liver injury (anti-TB DILI).

Keywords

• cost-effectiveness analysis
• decision trees analysis
• anti-tb dili
• pharmacoeconomics
• prospective